通策医疗
(600763)
| 流通市值：144.14亿 | | | 总市值：144.14亿 |
| 流通股本：4.44亿 | | | 总股本：4.44亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,586,118,351.78 | 755,289,213.29 | 2,913,101,528.81 | 2,290,207,568.44 |
| 营业总成本 | 1,116,871,540.34 | 528,626,816.22 | 2,250,412,202.89 | 1,651,816,530.61 |
| 其他经营收益 | | | | |
| 营业利润 | 600,450,727.05 | 242,145,066.69 | 708,012,052.36 | 686,914,819.32 |
| 利润总额 | 598,239,370.29 | 241,752,368.6 | 705,355,785.2 | 684,241,323.4 |
| 净利润 | 520,708,846.72 | 220,580,134.55 | 588,289,970.81 | 616,407,609.55 |
| 每股收益 | | | | |
| 其他综合收益 | -2,409,741.83 | -0.12 | -94,310,428.95 | 4,635,380.15 |
| 综合收益总额 | 518,299,104.89 | 220,580,134.43 | 493,979,541.86 | 621,042,989.7 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 817,465,833.01 | 1,179,667,772.41 | 1,140,362,133.19 | 905,438,308.14 |
| 非流动资产: | | | | |
| 非流动资产合计 | 5,172,041,860.11 | 5,059,397,496.42 | 5,020,551,352.56 | 5,373,460,526.99 |
| 资产总计 | 5,989,507,693.12 | 6,239,065,268.83 | 6,160,913,485.75 | 6,278,898,835.13 |
| 流动负债: | | | | |
| 流动负债合计 | 727,946,320.51 | 688,789,259.44 | 758,037,668.5 | 559,024,207.75 |
| 非流动负债: | | | | |
| 非流动负债合计 | 732,823,193.58 | 764,023,700.52 | 782,567,295.69 | 1,017,087,252.42 |
| 负债合计 | 1,460,769,514.09 | 1,452,812,959.96 | 1,540,604,964.19 | 1,576,111,460.17 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,136,586,725.49 | 4,420,895,942.57 | 4,285,170,856.34 | 4,343,706,814.81 |
| 股东权益合计 | 4,528,738,179.03 | 4,786,252,308.87 | 4,620,308,521.56 | 4,702,787,374.96 |
| 负债和股东权益合计 | 5,989,507,693.12 | 6,239,065,268.83 | 6,160,913,485.75 | 6,278,898,835.13 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,615,622,299.98 | 703,109,568.55 | 2,914,357,126.49 | 2,309,197,889.72 |
| 经营活动现金流出小计 | 1,215,271,746.78 | 542,145,980.63 | 2,103,638,499.81 | 1,627,578,446.45 |
| 经营活动产生的现金流量净额 | 400,350,553.2 | 160,963,587.92 | 810,718,626.68 | 681,619,443.27 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 14,590,595.44 | - | 16,483,333.85 | 13,091,162.64 |
| 投资活动现金流出小计 | 709,704,928.94 | 80,591,875 | 295,722,479.89 | 324,328,442.27 |
| 投资活动产生的现金流量净额 | -695,114,333.5 | -80,591,875 | -279,239,146.04 | -311,237,279.63 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 300,000,000 | 250,000,000 | 68,524,741 | 67,639,567.6 |
| 筹资活动现金流出小计 | 335,426,284.64 | 234,754,599.59 | 523,545,454.59 | 481,156,664.1 |
| 筹资活动产生的现金流量净额 | -35,426,284.64 | 15,245,400.41 | -455,020,713.59 | -413,517,096.5 |
| 汇率变动对现金及现金等价物的影响 | -0.21 | -0.11 | -0.16 | -0.08 |
| 现金及现金等价物净增加额 | -330,190,065.15 | 95,617,113.22 | 76,458,766.89 | -43,134,932.94 |
| 期末现金及现金等价物余额 | 366,825,516.82 | 791,934,559.69 | 696,317,446.47 | 576,723,746.64 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -330,190,065.15 | - | 76,458,766.89 | - |
最新报告期：2026-08-30| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 申万宏源 | 余玉君 | 1.34 | 1.52 | 1.68 | 2026-08-30 |
| 开源证券 | 阮帅,余汝意 | 1.40 | 1.64 | 1.97 | 2026-08-18 |
| 中金公司 | 夏璐,张琎,朱言音 | 1.30 | 1.43 | -- | 2026-08-17 |
| 华泰证券 | 代雯,高鹏 | 1.33 | 1.53 | 1.73 | 2026-08-14 |